¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѹæ»ç¼±Á¾¾çÇÐȸ 2022³â 40Â÷ Á¤±âÇмú´ëȸ(1ÀÏÂ÷) : 2022-10-13

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѹæ»ç¼±Á¾¾çÇÐȸ 2022³â 40Â÷ Á¤±âÇмú´ëȸ(1ÀÏÂ÷) : 2022-10-13
±³À°ÀÏÀÚ : 2022-10-13
±³À°Àå¼Ò : ·Ôµ¥È£ÅÚ(¼Ò°øµ¿)  
±³À°ÁÖÁ¦ : 2022³â 40Â÷ Á¤±âÇмú´ëȸ(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ
´ã´çÀÚ : ÃÖÇýÁø
¿¬¶ôó : 02-743-6574  
À̸ÞÀÏ : kosro@kosro.or.kr      
±³À°Á¾·ù : ¹æ»ç¼±Á¾¾çÇаú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í ¿ø·Îȸ¿ø:¹«·á Á¤È¸¿ø(Àü¹®ÀÇ) : 80,000¿ø ¼ö·Ãȸ¿ø : 50,000¿ø Ưº°È¸¿ø(ÀÇÇй°¸®/»ý¹°¹Ú»ç) : 50,000¿ø ÁØȸ¿ø : 30,000¿ø ºñȸ¿ø : 120,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-13 ·Ôµ¥È£ÅÚ 09:30~10:30 Radiation Oncologist  Silvia Formenti(Weill Cornell Medicine) 
±³À°½Ã°£ 10-13 ·Ôµ¥È£ÅÚ 10:30~11:10 Medical Oncologist  ±èÅÂÀ¯(¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 10-13 ·Ôµ¥È£ÅÚ 11:10~11:50 Recent trends in tumor immunology  ½ÅÀÇö(Çѱ¹°úÇбâ¼ú¿ø) 
±³À°½Ã°£ 10-13 ·Ôµ¥È£ÅÚ 11:50~12:00 Circulating tumor HPV-DNA kinetics in p16+ oropharyngeal cancer patients undergoing adaptive radiation de-escalation based on mid-treatment nodal response  Joseph Kim(NYU Langone Health) 
È޽Ġ10-13 ·Ôµ¥È£ÅÚ 11:50~13:00 È޽Ġ () 
±³À°½Ã°£ 10-13 ·Ôµ¥È£ÅÚ 13:00~13:50 Radiation Dose De-escalation Strategy in Definitive Concurrent Chemoradiotherapy for nasopharyngeal cancer   ¹®Áø¿µ(¿¬¼¼¾Ïº´¿ø) 
±³À°½Ã°£ 10-13 ·Ôµ¥È£ÅÚ 13:50~14:40 Impact of the new ESTRO-ACROP target volume delineation guideline on breast-related complications after implant-based reconstruction and postmastectomy radiotherapy  ¹ÚÁ¤ºó(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 10-13 ·Ôµ¥È£ÅÚ 14:40~15:30  Development of a new treatment modality to reduce post-radiation proctitis in prostate cancer: Magnetic Modulated Radiation Therapy (MMRT)  Á¤´©¸®Çö(°­¿ø´ëÇб³º´¿ø) 
È޽Ġ10-13 ·Ôµ¥È£ÅÚ 15:30~15:50 È޽Ġ () 
±³À°½Ã°£ 10-13 ·Ôµ¥È£ÅÚ 15:50~17:05 Theragnostics: Recent updates in Radionuclide Therapy  Ãµ±âÁ¤(¼­¿ï´ëÇб³) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ 2022³â 40Â÷ Á¤±âÇмú´ëȸ(1ÀÏÂ÷) : 2022-10-13""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °¡Å縯°üµ¿´ëÇб³±¹Á¦¼º¸ðº´¿ø ¾È¸é¸¶ºñ¿Í µÎ°æºÎ Á¾¾ç Ä¡·áÀÇ ÃֽŠÁö°ß : 2022-10-13
´ÙÀ½±Û ´ëÇÑÀ忬±¸ÇÐȸ ´ë±¸°æºÏÁöȸ 2022³â ´ÙÇÐÁ¦ ½ÉÆ÷Áö¾ö ÇÁ·Î±×·¥ : 2022-10-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 76 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 41 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 50 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 57 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 45 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 46 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 22 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 46 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 22 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 49 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 36 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 29 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷